Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 1;107(9):2244-2248.
doi: 10.3324/haematol.2022.281068.

A validated clinical-genetic score for assessing the risk of thrombosis in patients with COVID-19 receiving thromboprophylaxis

José Manuel Soria  1 , Sergi Mojal  2 , Angel Martinez-Perez  3 , Francisco René Acosta  2 , Sonia López  3 , Sara Miqueleiz  4 , Diana Rodriguez  4 , Maria Angeles Quijada  5 , Antonio Cardenas  3 , Francisco Vidal  6 , Angel Remacha  7 , Rosa Maria Antonijoan  5 , Juan Carlos Souto  2
Affiliations

A validated clinical-genetic score for assessing the risk of thrombosis in patients with COVID-19 receiving thromboprophylaxis

José Manuel Soria et al. Haematologica. .
No abstract available

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Predictive capacity of the different models. ROC curves are shown for each model: model with clinical variables only (M_CLIN); model with genetic variables only (M_GRS); and the combination of both models (M_TOTAL or TiC).
See this image and copyright information in PMC

References

    1. Porfidia A, Valeriani E, Pola R, et al. Venous thromboembolism in patients with COVID-19: Systematic review and meta-analysis. Thromb Res. 2020;196:67-74. - PMC - PubMed
    1. Chi G, Lee JJ, Jamil A, et al. Venous thromboembolism among hospitalized patients with COVID-19 undergoing thromboprophylaxis: a systematic review and meta-analysis. J Clin Med. 2020;9(8):2489. - PMC - PubMed
    1. Sadeghipour P, Talasaz AH, Rashidi F, et al. Effect of intermediate-dose vs standard-dose prophylactic anticoagulation on thrombotic events, extracorporeal membrane oxygenation treatment, or mortality among patients with COVID-19 admitted to the intensive care unit: the INSPIRATION randomized Clini. JAMA. 2021;325(16):1620-1630. - PMC - PubMed
    1. Souto JC, Almasy L, Borrell M, et al. Genetic susceptibility to thrombosis and its relationship to physiological risk factors: the GAIT study. Genetic Analysis of Idiopathic Thrombophilia. Am J Hum Genet. 2000;67(6):1452-1459. - PMC - PubMed
    1. Soria JM, Morange PE, Vila J, et al. Multilocus genetic risk scores for venous thromboembolism risk assessment. J Am Heart Assoc. 2014;3(5):1-10. - PMC - PubMed